This report is designed for the strategic executive and the savvy in-house counsel. It’s a guide to moving beyond the […]

In the pharmaceutical industry value is created not just in the laboratory but on the complex chessboard of international trade

Let’s be candid. The era of the single-modality blockbuster, the “one-pill-fits-all” small molecule or the “one-target” monoclonal antibody, is drawing

The Multi-Trillion-Dollar Pivot If you are an IP strategist, a business development leader, or an R&D chief in the pharmaceutical

Introduction: The High-Stakes Game of Pharmaceutical Lifecycles The lifecycle of a drug is a story of immense investment, groundbreaking science,

The intellectual property landscape for small molecule pharmaceuticals has never been more challenging or critical. As R&D costs soar and

For too long, Africa has been viewed through a monolithic lens—a single, challenging market characterized more by risk than by

Redefining Pharmaceutical Portfolio Management The management of a pharmaceutical Research and Development (R&D) portfolio is not a mere administrative function;

At its core, the patent system represents a grand bargain between innovator and society. In exchange for disclosing an invention,